Detechgene
PrivateLast Round
Seed
Aug 27, 2025
Total Funding Raised
$4.95M
Company Overview
Detechgene is a biotechnology company that has developed a mobile rapid test system for pathogens. The company's platform is designed to combine the precision of a PCR test with the user-friendliness of a rapid antigen test, delivering results in under 30 minutes for various viral, bacterial, and fungal pathogens. Founded in 2022 as a spin-off from the University Hospital Cologne, Detechgene aims to provide decentralized, on-site diagnostics for clinics, researchers, and individuals.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Medical Devices, Biotechnology, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Detechgene Comps
Public and private peers based on sector, stage, and business model.
Detechgene Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Aug 27, 2025 | ||||
| Grant | Jun 2, 2024 |
Key People
Founding team and executive leadership
Detechgene Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Meerkat Holding | Seed |
| neoteq ventures | Seed |
| NRW.Bank | Seed |
| Aquarius Invest GmbH | Seed |
| Campus Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 1, 2026
DIAGURIN project launched within the gesünder.in.nrw initiative.
- Nov 9, 2025
Received founding category recognition for innovative PCR rapid test.
Detechgene Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Detechgene's valuation, stock price, and market status.